Jindal Poly Films FPO vs Nectar Lifesciences IPO

Comparison between Jindal Poly Films FPO and Nectar Lifesciences IPO.

IPO Details

Jindal Poly Films FPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Nectar Lifesciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Jindal Poly Films FPO is whereas the issue size of the Nectar Lifesciences IPO is . The final issue price of Jindal Poly Films FPO is ₹360.00 per share and of Nectar Lifesciences IPO is ₹240.00 per share.

 Jindal Poly Films FPONectar Lifesciences IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹360.00 per share₹200.00 per share
Issue Price (Upper)₹400.00 per share₹240.00 per share
Issue Price (Final)₹360.00 per share₹240.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size83,33,325 shares38,70,000 shares
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total83,33,325 shares38,70,000 shares
Issue Size Total (Amount)

IPO Timetable

Jindal Poly Films FPO opens on Jun 09, 2005, while Nectar Lifesciences IPO opens on Jun 22, 2005. The closing date of Jindal Poly Films FPO and Nectar Lifesciences IPO is Jun 15, 2005, and Jun 28, 2005, respectively.

Financials & KPIs

Jindal Poly Films FPO P/E ratio is , as compared to Nectar Lifesciences IPO P/E ratio of .

Shares Offered

In the Jindal Poly Films FPO Retail Individual Investors (RII) are offered 29,16,665 shares while in Nectar Lifesciences IPO retail investors are offered 29,16,665 shares. Qualified Institutional Buyers (QIB) are offered 41,66,662 shares in Jindal Poly Films FPO and 19,35,000 shares in Nectar Lifesciences IPO.

 Jindal Poly Films FPONectar Lifesciences IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation
QIB41,66,662 shares19,35,000 shares
NII12,49,998 shares5,80,500 shares
RII29,16,665 shares13,54,500 shares
Employee
Others
Total83,33,325 shares38,70,000 shares

Bids Received (Subscription)

Jindal Poly Films FPO subscribed in total, whereas Nectar Lifesciences IPO subscribed .

Compare with others

Compare: